Program – Academic Symposium on “Frontiers in Biologics Development: Towards a Brighter Future for Thailand”

08:00 – 08:30	Registration
Session I: Opening Ceremony
08:30	– Guests to be seated in the Convention Hall
09:00	– Arrival of Professor Dr. Her Royal Highness Princess Chulabhorn Mahidol President of the Chulabhorn Research Institute, Thailand – *Report by Emeritus Professor Dr. Khunying* Mathuros Ruchirawat** Vice President for Research and Academic Affairs, Chulabhorn Research Institute, Thailand – Royal Address by Professor Dr. Her Royal Highness Princess Chulabhorn Mahidol – Video Presentation
09:20 – 09:35	A Tribute to Her Royal Highness Princess Chulabhorn Mahidol: Thailand’s Role in the Global Biologics Era Professor Ram Sasisekharan Massachusetts Institute of Technology, USA As Thailand emerges as a key player in biopharmaceutical innovation, this session offers a forward-looking perspective on how the country can shape the global future of biologics. With insights into new therapeutic frontiers and innovation ecosystems, this talk explores the strategic directions Thailand must take to become a true leader in translational medicine.
09:35 – 09:50	From Blackboard to Benchside : The Origin of Biologics in Thailand Professor John M. Essigmann Massachusetts Institute of Technology, USA This session traces the visionary roots of the Chulabhorn Research Institute, from its early days in teaching and basic science to its groundbreaking role in Thailand’s first successful biologics registration. A journey once considered a dream, now a national milestone in biomedical innovation.

09:50 – 10:30	Coffee Break
Session II – Regulatory and Clinical Innovations
10:30 – 10:50	Harmonizing for Health: Regulatory Innovation Across Border [virtual presentation] Dr. Janet Woodcock Former Principal Deputy Commissioner, U.S. FDA Regulatory science is undergoing a global shift—away from rigid rules and toward adaptive, evidence-based approaches. Delivered by a former US FDA expert, this session explores how international regulatory collaboration can accelerate access to safe, effective, and affordable biologics, especially in low- and middle-income regions. A must-attend for those navigating regulatory pathways in an interconnected world.
10:50 – 11:10	From Resistant to Resilience: AMR as a Case Study for Clinical Innovation *Professor Helen Boucher (M.D.)* Dean of Tufts Medical School and Chief Academic Officer of Tufts Medicine, USA Antimicrobial resistance (AMR) is not just a crisis—it’s an opportunity to rethink how we conduct and regulate clinical research. This session, led by a global authority on AMR trials, will use real-world case studies to illustrate how science-driven, flexible regulatory strategies can transform crisis response into long-term innovation for global health.


Session III – Panel Discussions
11:10 – 11:50	Biologics in the Future of Cancer Care Moderator – Professor John M. Essigmann – Professor Ram Sasisekharan Panelists – Dr. Trairak *Pisitkun* *– Dr. Uma Narayanasami* *– Dr. Janet Woodcock* [virtual presentation] With oncology leading the way in biologics innovation, this panel brings together experts to discuss the evolving landscape of cancer therapeutics—from monoclonal antibodies to personalized treatments. Learn how emerging trends are reshaping clinical strategy, manufacturing, and regulatory review in one of the most dynamic fields in modern medicine.
11.50 – 12.30	Transforming Rare Disease access through Innovation Moderator – Professor Ram Sasisekharan Panelists – Ms. Worasuda Yoongthong *– Professor Ram Sasisekharan* *– Dr. Janet Woodcock* [virtual presentation] *– Professor Tan Chuen Wen* *– Professor Jenny Low* Rare diseases represent some of the most urgent and complex challenges in healthcare. This discussion will examine how cutting-edge science, novel clinical approaches, and patient-centered regulatory frameworks are converging to improve access to biologics for rare disease populations.
12:30 – 13.15	Buffet Lunch
13.15 – 14.00	Advanced Analytics and Reinventing Biomanufacturing for the Next Era Moderator – Professor Ram Sasisekharan Panelists – Ms. Worasuda Yoongthong *– Professor Ram Sasisekharan* *– Professor Jenny Low* – Professor Bernard Arulanandam *– Associate Professor Mayuree Fuangthong* Biomanufacturing is evolving rapidly, powered by data-driven analytics, automation, and precision quality control. In this panel, leading scientists and regulators explore how next-generation technologies can enhance speed without compromising safety—ushering in a new paradigm of scalable, agile, and compliant biologics production.

SCIENTIFIC PROGRAM